Clinical Trial Update: Ruxolitinib for Adult T-Cell Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ruxolitinib in adult T-cell leukemia across Phase 1 and Phase 2, with terminated status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-i Associated T-cell Leukemia
• T-cell Leukemia
• T-cell Leukemia Adult

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: T Cell Leukemia, Adult, Leukemia, Adult T-Cell | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-01-10